Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramsay Generale dente's Other Operating Expense for the
three
months ended in Dec. 2025 was €0 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €2,313 Mil.
Ramsay Generale dente's quarterly Other Operating Expense
declined
from Mar. 2025 (€1,341 Mil) to Jun. 2025 (€1,274 Mil) and
declined
from Jun. 2025 (€1,274 Mil) to Dec. 2025 (€0 Mil).
Ramsay Generale dente's annual Other Operating Expense
increased
from Jun. 2023 (€3,503 Mil) to Jun. 2024 (€3,758 Mil) and
increased
from Jun. 2024 (€3,758 Mil) to Jun. 2025 (€3,898 Mil).
Ramsay Generale dente Other Operating Expense Related Terms
Ramsay Generale dente Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Ramsay Generale dente's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Generale dente Other Operating Expense Chart
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,313 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of €2,313 Mil mean?
Ramsay Generale dente (FRA:GD6) has a Other Operating Expense of €2,313 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Ramsay Generale dente and its competitors.
Is Ramsay Generale dente's Other Operating Expense too high?
Ramsay Generale dente's current Other Operating Expense is €2,313 Mil. Overall, Ramsay Generale dente has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Ramsay Generale dente's Other Operating Expense compare to HCA and THC?
Ramsay Generale dente's Other Operating Expense of €2,313 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Ramsay Generale dente and its competitors. Ramsay Generale dente's current Other Operating Expense is €2,313 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Generale dente stock overvalued right now?
Ramsay Generale dente (FRA:GD6) has a current Other Operating Expense of €2,313 Mil. The stock's GF Value™ is €21.29, compared to a current price of €10.85 — trading 49% below its estimated fair value. The current Other Operating Expense is €2,313 Mil. Ramsay Generale dente's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Ramsay Generale dente (FRA:GD6), the current Other Operating Expense is €2,313 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Generale dente (FRA:GD6) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Generale dente stock appears to be undervalued.
The current stock price of €10.85 is trading 49% below its estimated GF Value™ of €21.29.
Key valuation signals for FRA:GD6:
Other Operating Expense: €2,313 Mil
GF Value™: €21.29 vs. price of €10.85 (49% below fair value)
No single metric tells the full story. See the FRA:GD6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.
69GF Score
Get the complete analysis for FRA:GD6
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:GD6 has been successfully added to your 
